COVID-19 pandemic: different roles for scientific publications and funding face to epidemiological data-an European, country-based perspective.

Q2 Medicine

Clinical and Molecular Allergy Pub Date : 2021-09-13 DOI:10.1186/s12948-021-00154-9

Alessandro Tonacci, Sara Genovese, Giovanni Pioggia, Sebastiano Gangemi

{"title":"COVID-19 pandemic: different roles for scientific publications and funding face to epidemiological data-an European, country-based perspective.","authors":"Alessandro Tonacci, Sara Genovese, Giovanni Pioggia, Sebastiano Gangemi","doi":"10.1186/s12948-021-00154-9","DOIUrl":null,"url":null,"abstract":"<p><p>COVID-19 has represented an unprecedented challenge to be faced also concerning the spread of information, with scientific literature being often the sole source of trustworthy knowledge for the global community. However, a massive waste in research was noticed during pandemic, preventing the scientists to produce totally novel and original results, and the citizenship to have the complete support they needed from science. The present work investigated the relationship between planned funding, research grants, scientific publications and epidemiology in the 27 EU countries, retrieving a significant correlation between scientific publications and COVID-19 cases and deaths, as well as with economic data. Interestingly, planned coronavirus-devoted funds were correlated with lower GDP per capita and higher mortality, leading to the hypothesis for a lack of translation into real funds allowed to the respective country, or for a significant research waste, not transformed into a tangible product or effect. Such results could suggest the need for a different approach in the future concerning the redistribution of research funds in case of COVID-19 relapse or future pandemic events.</p>","PeriodicalId":38753,"journal":{"name":"Clinical and Molecular Allergy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435404/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Molecular Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12948-021-00154-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

COVID-19 has represented an unprecedented challenge to be faced also concerning the spread of information, with scientific literature being often the sole source of trustworthy knowledge for the global community. However, a massive waste in research was noticed during pandemic, preventing the scientists to produce totally novel and original results, and the citizenship to have the complete support they needed from science. The present work investigated the relationship between planned funding, research grants, scientific publications and epidemiology in the 27 EU countries, retrieving a significant correlation between scientific publications and COVID-19 cases and deaths, as well as with economic data. Interestingly, planned coronavirus-devoted funds were correlated with lower GDP per capita and higher mortality, leading to the hypothesis for a lack of translation into real funds allowed to the respective country, or for a significant research waste, not transformed into a tangible product or effect. Such results could suggest the need for a different approach in the future concerning the redistribution of research funds in case of COVID-19 relapse or future pandemic events.

Abstract Image

查看原文本刊更多论文

COVID-19 大流行：科学出版物和资金对流行病学数据的不同作用--以欧洲国家为基础的视角。

COVID-19 在信息传播方面也面临着前所未有的挑战，科学文献往往是全球社会唯一值得信赖的知识来源。然而，在大流行病期间，人们注意到研究方面出现了大量浪费，科学家们无法取得完全新颖的原创性成果，公民也无法从科学中获得所需的全面支持。本研究调查了欧盟 27 个国家的计划资金、研究补助金、科学出版物和流行病学之间的关系，发现科学出版物与 COVID-19 病例和死亡人数以及经济数据之间存在显著相关性。有趣的是，冠状病毒计划拨款与人均国内生产总值（GDP）较低和死亡率较高相关，这导致了一种假设，即相关国家所获得的资金没有转化为实际资金，或者存在严重的研究浪费，没有转化为实际产品或效果。这些结果表明，在 COVID-19 复发或未来发生大流行病的情况下，需要采取不同的方法重新分配研究资金。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Molecular Allergy Medicine-Immunology and Allergy

CiteScore

8.20

自引率

0.00%

发文量

审稿时长

13 weeks

期刊介绍： Clinical and Molecular Allergy is an open access, peer-reviewed, online journal that publishes research on human allergic and immunodeficient disease (immune deficiency not related to HIV infection/AIDS). The scope of the journal encompasses all aspects of the clinical, genetic, molecular and inflammatory aspects of allergic-respiratory (Type 1 hypersensitivity) and non-AIDS immunodeficiency disorders. However, studies of allergic/hypersensitive aspects of HIV infection/AIDS or drug desensitization protocols in AIDS are acceptable. At the basic science level, this includes original work and reviews on the genetic and molecular mechanisms underlying the inflammatory response.